Early-Onset Parkinson Disease in 22q11.2 Deletion Syndrome:Diagnostic Challenges in a Patient With Schizophrenia.A Case Report
Objective: To highlight 22q11.2 deletion syndrome (22q11.2DS) as an underrecognized genetic cause of early-onset Parkinson disease (EOPD) and to describe the diagnostic challenges in patients…Cerebellar Syndrome and Parkinsonism Associated with Acquired Hepatocerebral Degeneration with Unusual Findings on Neuroimaging.
Objective: To present a clinical case of cerebellar syndrome and parkinsonism linked to acquired hepatocerebral degeneration exhibiting atypical radiological abnormalities. Background: Acquired hepatocerebral degeneration (AHCD)…Carvacrol modulates rotenone-induced Nigrostriatal Neuronal Death and Angiogenesis via targeting AMPK/FOXO3 transcription factor O3 Signaling cascade
Objective: With an eye toward its effects on striatal angiogenesis and the AMPK/ FOXO3 transcription factor O3 pathway, this work attempts to investigate the neuroprotective…40,000 Instrumented Timed-up-and-go Tests – Standardization is within Reach
Objective: Timed-up-and-go (TUG) is a standard test in neurological assessment. TUG completion time is currently the only quantitative result reported and matched against age and…Drug-induced parkinsonism with resting tremor
Objective: Resting tremor might be developed by long-term treatment of dopamine receptor antagonists in cases of drug-induced parkinsonism Background: Resting tremor is one of the…Parkinsonism following Chronic Disulfiram Overdose
Objective: To describe the effect of chronic intake of disulfiram Background: Background- Drug induced parkinsonism is one of the commonest causes of non-degenerative parkinsonism. Typical…Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine
Objective: To understand the pattern of movement disorders caused by migraine prophylactic medicine such as flunarizine. Background: Migraine prophylactic treatments are usually taken for short…Neuroprotective Role of Diosgenin-Loaded Lipid Nanoparticles for Parkinson’s Disease: Pharmacokinetic and Pharmacodynamic Insights
Objective: To develop, optimize, and evaluate diosgenin-loaded solid lipid nanoparticles (DG-SLNs) and nanostructured lipid carriers (DG-NLCs) incorporated into hydrogel formulations (DG-SLN-C and DG-NLC-C) for improved…Association between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link?
Objective: To perform a meta-analysis to show the association between different Antiepileptic Drugs(AEDs) and Parkinson’s disease(PD). Background: PD is a neurodegenerative disorder affecting 1-2% of…Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol
Objective: To reproduce the side effects of antipsychotic drugs (drug-induced Parkinsonism and tardive dyskinesia) in rats and elucidate its pathomechanism by examining morphological changes in…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 11
- Next Page »